Shopping Cart

Imagion Biosystems Initiates MagSense® Instrument Development

Imagion Biosystems Initiates MagSense® Instrument Development


Notice: Undefined index: file in /nas/content/live/imagionbx/wp-includes/media.php on line 1686

Imagion Biosystems Limited (Imagion, ASX:IBX) has entered into a Service Agreement with StarFish Medical (“StarFish”), Canada’s largest medical device design, development and contract manufacturing company, to assist in the design and development of the MagSense instrument platform for clinical applications.
View the ASX announcement, “Imagion Biosystems Initiates MagSense Instrument Development.”

Related Articles

2023 AGM Resolution Overview

Video Transcript: Robert Proulx, Imagion Biosystems’ President & CEO: [00:00:00] On April 24th, we sent out the notice of meeting for our annual general meeting

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.